Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)-Health Disparities Subcommittee (HDS), 43547 [2017-19779]

Download as PDF 43547 Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices approved for the 2014 revision. This reflects both a slight decrease in the anticipated number of Health Hazard Evaluation requests (300 to 290) as well as changes in the response requirements of requests received based upon recent program experience. Number of respondents Number of responses per respondent Average burden per response (in hours) Type of respondent Form Employees/employee representatives/or employers. Employees ...................................................... Health Hazard Evaluation Request Form ...... 290 1 12/60 Health Hazard Evaluation specific interview example. Health Hazard Evaluation specific questionnaire example. Employee Contact Postcard .......................... Initial Site Visit Followback Survey form ........ 2,580 1 15/60 3,700 1 30/60 2,150 244 1 1 5/60 10/60 Closeout for Health Hazard Evaluation Followback Survey with site visit. 1 Year Later for Health Hazard Evaluation Followback Survey with site visit. Closeout for Health Hazard Evaluation without site visit. 244 1 20/60 244 1 15/60 98 1 10/60 1 Year Later for Health Hazard Evaluation without site visit. 98 1 15/60 Employees ...................................................... Employees ...................................................... Follow-back for onsite evaluations—employer & employee representative Year 1. Employer & employee representative Year 1 Employer & employee representative Year 2 Follow-back for evaluations without onsite— employer & employee representative Year 1. Employer & employee representative Year 2 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2017–19744 Filed 9–15–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC)—Health Disparities Subcommittee (HDS) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee to the Director, Centers for Disease Control and Prevention—Health Disparities Subcommittee (ACD, CDC– HDS). This meeting is open to the public, limited only by the room that accommodates 45 people and audio phone line that accommodates 50 callers. The public is also welcome to listen to the meeting by dialing 866– 918–8397 and enter code 9346283, this conference line is available to the first 50 callers. The public comment period sradovich on DSKBBY8HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:54 Sep 15, 2017 Jkt 241001 is from 9:45 a.m. to 9:50 a.m. and 3:45 p.m. to 3:55 p.m. The deadline to register for in-person attendance and/or notice of intent to make oral or written comment is October 30, 2017. To register, please send an email to ACDirector@cdc.gov. DATES: The meeting will be held on November 9, 2017, 8:30 a.m. to 4:00 p.m. ET. ADDRESSES: CDC, Building 21, 12th Floor, Rooms 12105–12101, 1600 Clifton Road NE., Atlanta, Georgia 30329. Bridge line: 866–918–8397 and enter code 9346283. FOR FURTHER INFORMATION CONTACT: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S K–77, Atlanta, Georgia 30329. Telephone (404) 498– 6482, Email: ACDirector@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The Subcommittee will provide counsel to ACD, CDC on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. Matters to be Considered: The Health Disparities Subcommittee Agenda will include discussions on addressing health disparities in achieving the agency’s overarching health impact goals including selected observations from the HDS for the ACD, CDC to consider, and on progress of the HDS, and on progress toward activities related to data disaggregation and childhood PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 trauma. Agenda items are subject to change as priorities dictate. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–19779 Filed 9–15–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This meeting is SUMMARY: E:\FR\FM\18SEN1.SGM 18SEN1

Agencies

[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Page 43547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19779]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)--Health Disparities Subcommittee (HDS)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Committee to the Director, Centers 
for Disease Control and Prevention--Health Disparities Subcommittee 
(ACD, CDC-HDS). This meeting is open to the public, limited only by the 
room that accommodates 45 people and audio phone line that accommodates 
50 callers. The public is also welcome to listen to the meeting by 
dialing 866-918-8397 and enter code 9346283, this conference line is 
available to the first 50 callers. The public comment period is from 
9:45 a.m. to 9:50 a.m. and 3:45 p.m. to 3:55 p.m. The deadline to 
register for in-person attendance and/or notice of intent to make oral 
or written comment is October 30, 2017. To register, please send an 
email to ACDirector@cdc.gov.

DATES: The meeting will be held on November 9, 2017, 8:30 a.m. to 4:00 
p.m. ET.

ADDRESSES: CDC, Building 21, 12th Floor, Rooms 12105-12101, 1600 
Clifton Road NE., Atlanta, Georgia 30329.
    Bridge line: 866-918-8397 and enter code 9346283.

FOR FURTHER INFORMATION CONTACT: Leandris Liburd, Ph.D., M.P.H., M.A., 
Designated Federal Officer, Health Disparities Subcommittee, Advisory 
Committee to the Director, CDC, 1600 Clifton Road NE., M/S K-77, 
Atlanta, Georgia 30329. Telephone (404) 498-6482, Email: 
ACDirector@cdc.gov.

SUPPLEMENTARY INFORMATION: 
    Purpose: The Subcommittee will provide counsel to ACD, CDC on 
strategic and other health disparities and health equity issues and 
provide guidance on opportunities for CDC.
    Matters to be Considered: The Health Disparities Subcommittee 
Agenda will include discussions on addressing health disparities in 
achieving the agency's overarching health impact goals including 
selected observations from the HDS for the ACD, CDC to consider, and on 
progress of the HDS, and on progress toward activities related to data 
disaggregation and childhood trauma. Agenda items are subject to change 
as priorities dictate.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2017-19779 Filed 9-15-17; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.